Assen Kelchev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Assen Kelchev has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
S. Kazakov
Acibadem City Clinic UMBAL Vitosha, Sofia, Bulgaria
3 shared publications- Kristiyanna M. Mavrodieva
Acibadem City Clinic Vitosha Hospital, Sofia, Bulgaria
2 shared publications - Andrey S. Neutov
Department of Heart Surgery, City Clinic-Achubadem, Sofia University Sofia, Sofia, Bulgaria
1 shared publication - Anelia Partenova
Department of Diagnostic Imaging, National Heart Hospital, Sofia, Bulgaria
1 shared publication Boyan Kunev
Cardiology Clinic, National Heart Hospital, Sofia, Bulgaria
1 shared publication- Dimitar Nikolov
Acibadem City Clinic, UMHAT TOKUDA, Sofia, Bulgaria
1 shared publication
Latest Publications
- Open Access
- 18 September 2026
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 32 (2) , 78-99
Frozen Elephant Trunk procedure with E-Vita Open NEO: Initial experience at Acibadem City Clinic Hospital Vitosha
Background: Extensive aortic arch and proximal descending aortic pathologies traditionally require multi-stage repair. The Frozen Elephant Trunk (FET) technique allows one-stage ascending aorta and total arch replacement with antegrade stent-graft deployment, enabling complete repair and a platform for future endovascular interventions. The E-vita Open NEO hybrid prosthesis incorporates design improvements that facilitate deployment, shorten ischemic times, and reduce the risk of neurological complications. Objective: The main objective of this case series is to present the initial experience with FET using the E-vita Open NEO graft at Acibadem City Clinic Hospital Vitosha, illustrating feasibility, safety, and early outcomes. Methods: Four elective patients with complex thoracic aortic disease (degenerative aneurysms and chronic post-dissection aneurysms) underwent ascending aorta and total arch replacement with FET using the E-vita Open NEO prosthesis. Procedures were performed via median sternotomy with cardiopulmonary bypass, hypothermic circulatory arrest, and selective antegrade cerebral perfusion. Trifurcated or branched grafts were selected according to arch anatomy. Results: All patients survived with no in-hospital mortality, stroke, or spinal cord injury. Circulatory arrest times ranged 45–60 minutes. Postoperative imaging confirmed correct stent deployment, patent arch branches, and favorable aortic remodeling, including false lumen thrombosis in dissection cases. The device facilitated precise distal deployment and simplified arch reconstruction without graft-related complications. Conclusions: FET with the E-vita Open NEO is feasible and safe in a newly established aortic program. One-stage repair achieved complete anatomical correction, avoided staged procedures, and promoted early aortic remodeling. Early outcomes are consistent with international experience, supporting FET as a standard approach for extensive thoracic aortic disease.
- 18 September 2026
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 32 (2) , 78-99
Open AccessFrozen Elephant Trunk procedure with E-Vita Open NEO: Initial experience at Acibadem City Clinic Hospital Vitosha
Background: Extensive aortic arch and proximal descending aortic pathologies traditionally require multi-stage repair. The Frozen Elephant Trunk (FET) technique allows one-stage ascending aorta and total arch replacement with antegrade stent-graft deployment, enabling complete repair and a platform for future endovascular interventions. The E-vita Open NEO hybrid prosthesis incorporates design improvements that facilitate deployment, shorten ischemic times, and reduce the risk of neurological complications. Objective: The main objective of this case series is to present the initial experience with FET using the E-vita Open NEO graft at Acibadem City Clinic Hospital Vitosha, illustrating feasibility, safety, and early outcomes. Methods: Four elective patients with complex thoracic aortic disease (degenerative aneurysms and chronic post-dissection aneurysms) underwent ascending aorta and total arch replacement with FET using the E-vita Open NEO prosthesis. Procedures were performed via median sternotomy with cardiopulmonary bypass, hypothermic circulatory arrest, and selective antegrade cerebral perfusion. Trifurcated or branched grafts were selected according to arch anatomy. Results: All patients survived with no in-hospital mortality, stroke, or spinal cord injury. Circulatory arrest times ranged 45–60 minutes. Postoperative imaging confirmed correct stent deployment, patent arch branches, and favorable aortic remodeling, including false lumen thrombosis in dissection cases. The device facilitated precise distal deployment and simplified arch reconstruction without graft-related complications. Conclusions: FET with the E-vita Open NEO is feasible and safe in a newly established aortic program. One-stage repair achieved complete anatomical correction, avoided staged procedures, and promoted early aortic remodeling. Early outcomes are consistent with international experience, supporting FET as a standard approach for extensive thoracic aortic disease.
- Open Access
- 18 September 2026
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 32 (2) , 100-105
Minimally invasive ascending aortic surgery with partial upper sternotomy: Institutional experience and contemporary perspective
Background: Surgical replacement of the ascending aorta remains the gold standard therapy for ascending aortic aneurysm, chronic dissection, and selected aortic root pathologies. Traditionally performed through full median sternotomy, ascending aortic surgery has progressively evolved toward minimally invasive approaches aiming to reduce surgical trauma while preserving procedural safety and durability. Upper partial sternotomy has emerged as the most widely adopted minimally invasive access for ascending aortic surgery. This study presents the institutional experience of Acibadem City Clinic Vitosha Hospital with minimally invasive ascending aortic surgery via upper partial sternotomy and places these results in the context of contemporary literature. Methods: A retrospective analysis was conducted of consecutive elective patients undergoing ascending aortic replacement with or without aortic root intervention through an upper partial sternotomy. Demographic characteristics, operative details, and early postoperative outcomes were analyzed. Institutional results were interpreted considering current evidence comparing partial sternotomy with conventional full sternotomy, as well as alternative minimally invasive approaches including transaxillary and totally endoscopic techniques. Results: Minimally invasive ascending aortic surgery via upper partial sternotomy was associated with excellent early outcomes, including absence of early mortality, low neurological complication rates, limited blood transfusion requirements, and short intensive care and hospital stays. Cardiopulmonary bypass and aortic cross-clamp times were within acceptable ranges and comparable to those reported for conventional sternotomy in the literature. Conclusions: Upper partial sternotomy is a safe, reproducible, and effective minimally invasive approach for ascending aortic surgery in carefully selected patients. When performed in experienced centers, this technique provides outcomes comparable to full sternotomy while offering potential advantages in postoperative recovery. It represents a pragmatic and scalable strategy within the expanding field of minimally invasive aortic surgery.
- 18 September 2026
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 32 (2) , 100-105
Open AccessMinimally invasive ascending aortic surgery with partial upper sternotomy: Institutional experience and contemporary perspective
Background: Surgical replacement of the ascending aorta remains the gold standard therapy for ascending aortic aneurysm, chronic dissection, and selected aortic root pathologies. Traditionally performed through full median sternotomy, ascending aortic surgery has progressively evolved toward minimally invasive approaches aiming to reduce surgical trauma while preserving procedural safety and durability. Upper partial sternotomy has emerged as the most widely adopted minimally invasive access for ascending aortic surgery. This study presents the institutional experience of Acibadem City Clinic Vitosha Hospital with minimally invasive ascending aortic surgery via upper partial sternotomy and places these results in the context of contemporary literature. Methods: A retrospective analysis was conducted of consecutive elective patients undergoing ascending aortic replacement with or without aortic root intervention through an upper partial sternotomy. Demographic characteristics, operative details, and early postoperative outcomes were analyzed. Institutional results were interpreted considering current evidence comparing partial sternotomy with conventional full sternotomy, as well as alternative minimally invasive approaches including transaxillary and totally endoscopic techniques. Results: Minimally invasive ascending aortic surgery via upper partial sternotomy was associated with excellent early outcomes, including absence of early mortality, low neurological complication rates, limited blood transfusion requirements, and short intensive care and hospital stays. Cardiopulmonary bypass and aortic cross-clamp times were within acceptable ranges and comparable to those reported for conventional sternotomy in the literature. Conclusions: Upper partial sternotomy is a safe, reproducible, and effective minimally invasive approach for ascending aortic surgery in carefully selected patients. When performed in experienced centers, this technique provides outcomes comparable to full sternotomy while offering potential advantages in postoperative recovery. It represents a pragmatic and scalable strategy within the expanding field of minimally invasive aortic surgery.
- Open Access
- 5 May 2026
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 32 (1) , 99-112
Contemporary approach to valve-sparing surgery of the aortic root: the David procedure
Aneurysmal dilatation of the aortic root and ascending aorta is frequently associated with functional aortic regurgitation due to distortion of aortic root geometry, including dilatation of the annulus and the sinotubular junction, in the presence of morphologically preserved valve cusps. The classic surgical approach – composite aortic root replacement (Bentall-De Bono) – provides radical correction but is limited by the drawbacks of valve substitution, namely lifelong anticoagulation with mechanical prostheses or limited structural durability with the potential need for reintervention in bioprosthetic valves. Over recent decades, valve-sparing operations have become a preferred approach in appropriately selected patients. The David reimplantation technique provides annular stabilisation and control of dilatation of both the aortic root and the sinotubular junction while preserving the native aortic valve. Use of a Valsalva graft facilitates a more physiological root geometry, potentially optimising valvulo-aortic hemodynamics and cusp kinematics. The procedure also allows concomitant cusp repair when necessary to achieve optimal coaptation. The available literature consistently demonstrates low early operative mortality and excellent long-term durability of valve preservation in experienced centers, with high freedom from reoperation and a low incidence of clinically signifi cant aortic regurgitation at follow-up. European recommendations support valve-sparing strategies in younger patients with a dilated aortic root and preserved cusps when performed in specialized centers. Our experience at Acibadem City Clinic Hospital Vitosha since implementation of the technique in 2018 is consistent with published data, with good early hemodynamic results and favourable clinical evolution during follow-up. David valve-sparing aortic root replacement using a Valsalva graft according to the De Paulis method represents an anatomically grounded and highly effective strategy that combines radical correction of root pathology with preservation of the native valve and avoidance of prosthesis-related complications.
- 5 May 2026
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 32 (1) , 99-112
Open AccessContemporary approach to valve-sparing surgery of the aortic root: the David procedure
Aneurysmal dilatation of the aortic root and ascending aorta is frequently associated with functional aortic regurgitation due to distortion of aortic root geometry, including dilatation of the annulus and the sinotubular junction, in the presence of morphologically preserved valve cusps. The classic surgical approach – composite aortic root replacement (Bentall-De Bono) – provides radical correction but is limited by the drawbacks of valve substitution, namely lifelong anticoagulation with mechanical prostheses or limited structural durability with the potential need for reintervention in bioprosthetic valves. Over recent decades, valve-sparing operations have become a preferred approach in appropriately selected patients. The David reimplantation technique provides annular stabilisation and control of dilatation of both the aortic root and the sinotubular junction while preserving the native aortic valve. Use of a Valsalva graft facilitates a more physiological root geometry, potentially optimising valvulo-aortic hemodynamics and cusp kinematics. The procedure also allows concomitant cusp repair when necessary to achieve optimal coaptation. The available literature consistently demonstrates low early operative mortality and excellent long-term durability of valve preservation in experienced centers, with high freedom from reoperation and a low incidence of clinically signifi cant aortic regurgitation at follow-up. European recommendations support valve-sparing strategies in younger patients with a dilated aortic root and preserved cusps when performed in specialized centers. Our experience at Acibadem City Clinic Hospital Vitosha since implementation of the technique in 2018 is consistent with published data, with good early hemodynamic results and favourable clinical evolution during follow-up. David valve-sparing aortic root replacement using a Valsalva graft according to the De Paulis method represents an anatomically grounded and highly effective strategy that combines radical correction of root pathology with preservation of the native valve and avoidance of prosthesis-related complications.
- Open Access
- 5 May 2026
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 32 (1) , 87-98
The “Monster aorta” and how to deal with it
Introduction: The term “monster aorta” is a non-formal colloquial expression of advanced aortic disease. Features of the monster aorta phenotype include large aneurysm (> 6 cm), multisegmented involvement, hostile atheroma, chronic dissection, redo surgery, and emergency conditions. Although the literature commonly refers to these cases as “complex aortic pathology”, we propose the descriptive term “Monster Aorta” to emphasize the extraordinary anatomical complexity and technical challenges associated with such procedures. These operations frequently require multi-segment aortic reconstruction and demand management by a dedicated high-volume surgical team experienced in advanced perfusion techniques and cerebral protection strategies. The phrase “monster aorta” appears only rarely in the literature and generally in an informal descriptive context rather than as a formally defi ned clinical entity, illustrating the use of the term as a descriptive characterization of extreme aortic pathology rather than an established diagnostic designation. Objectives: The aim of the study is to establish the defi nition of monster aorta for clinical purposes and to offer best-practice recommendations. Materials and Methods: This is a single-center retrospective observational study of patients who underwent thoracic aortic surgery with monster aorta phenotype. Eight consecutive cases were described individually with respect to cannulation strategies, cerebral protection, frozen elephant trunk (FET) deployment, spinal cord protection, as well as various safeguards and pitfalls. Primary outcome measures were survival and neurologic complications. Results: No hospital mortality occurred and all patient were neurologically intact on discharge. All patients are alive to date. Discussion and Conclusion: This article demonstrates the strategies applied in the surgical treatment of monster aorta pathology in the Department of Cardiac Surgery, Acibadem City Clinic Vitosha Hospital. Based on the favorable postoperative results these surgical strategies seem to be effective and reproducible. The concept of monster aorta is useful in patient’s referral to high-volume centers specialized in thoracic aortic surgery.
- 5 May 2026
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 32 (1) , 87-98
Open AccessThe “Monster aorta” and how to deal with it
Introduction: The term “monster aorta” is a non-formal colloquial expression of advanced aortic disease. Features of the monster aorta phenotype include large aneurysm (> 6 cm), multisegmented involvement, hostile atheroma, chronic dissection, redo surgery, and emergency conditions. Although the literature commonly refers to these cases as “complex aortic pathology”, we propose the descriptive term “Monster Aorta” to emphasize the extraordinary anatomical complexity and technical challenges associated with such procedures. These operations frequently require multi-segment aortic reconstruction and demand management by a dedicated high-volume surgical team experienced in advanced perfusion techniques and cerebral protection strategies. The phrase “monster aorta” appears only rarely in the literature and generally in an informal descriptive context rather than as a formally defi ned clinical entity, illustrating the use of the term as a descriptive characterization of extreme aortic pathology rather than an established diagnostic designation. Objectives: The aim of the study is to establish the defi nition of monster aorta for clinical purposes and to offer best-practice recommendations. Materials and Methods: This is a single-center retrospective observational study of patients who underwent thoracic aortic surgery with monster aorta phenotype. Eight consecutive cases were described individually with respect to cannulation strategies, cerebral protection, frozen elephant trunk (FET) deployment, spinal cord protection, as well as various safeguards and pitfalls. Primary outcome measures were survival and neurologic complications. Results: No hospital mortality occurred and all patient were neurologically intact on discharge. All patients are alive to date. Discussion and Conclusion: This article demonstrates the strategies applied in the surgical treatment of monster aorta pathology in the Department of Cardiac Surgery, Acibadem City Clinic Vitosha Hospital. Based on the favorable postoperative results these surgical strategies seem to be effective and reproducible. The concept of monster aorta is useful in patient’s referral to high-volume centers specialized in thoracic aortic surgery.
- Open Access
- 18 December 2025
- Published by Pensoft Publishers in Folia Medica
- Vol. 67 (6)
Papillary fibroelastoma in an unusual location: arising from the left atrial endocardium
Papillary fibroelastoma (PFE) is a rare, benign cardiac tumor, often asymptomatic and typically arising from the valvular endocardium. While predominantly located on the heart valves, involvement of the atrial chamber is exceptionally uncommon. This case report presents a 34-year-old female with a history of ischemic stroke, in whom a left atrial mass was subsequently identified. Notably, the tumor was attached to the left atrial endocardium near the left atrial appendage orifice and the anterior mitral leaflet, an unusual location for PFE that made diagnosis difficult. Initially suspected to be a myxoma, the lesion was definitively diagnosed as a papillary fibroelastoma following histopathological examination. This case underscores the importance of advanced imaging techniques, meticulous preoperative evaluation, and histological confirmation in diagnosing and managing cardiac tumors in unusual locations.
- 18 December 2025
- Published by Pensoft Publishers in Folia Medica
- Vol. 67 (6)
Open AccessPapillary fibroelastoma in an unusual location: arising from the left atrial endocardium
Papillary fibroelastoma (PFE) is a rare, benign cardiac tumor, often asymptomatic and typically arising from the valvular endocardium. While predominantly located on the heart valves, involvement of the atrial chamber is exceptionally uncommon. This case report presents a 34-year-old female with a history of ischemic stroke, in whom a left atrial mass was subsequently identified. Notably, the tumor was attached to the left atrial endocardium near the left atrial appendage orifice and the anterior mitral leaflet, an unusual location for PFE that made diagnosis difficult. Initially suspected to be a myxoma, the lesion was definitively diagnosed as a papillary fibroelastoma following histopathological examination. This case underscores the importance of advanced imaging techniques, meticulous preoperative evaluation, and histological confirmation in diagnosing and managing cardiac tumors in unusual locations.
- Open Access
- 31 December 2023
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 29 (4) , 97-100
Subacute right ventricular perforation from a passive fixation pacemaker lead - a multidisciplinary diagnostic and management work-up
Процедурата за имплантиране на сърдечни имплантируеми електронни устройства (CIEDs) има процент на усложнения от около 5-6% според повечето проучвания. Перфорацията от електрод е възможно и сериозно нежелано събитие, което може да се прояви със спектър от симптоми – от липса на такива до внезапна сърдечна смърт. Средствата за диагностика при съмнение за перфорация са рентгеново изследване, трансторакална ехокардиография, изследване на пейсмейкърната функция и компютърна томография, като последната е златен стандарт. Екстракццията на електрода, довел до перфорацията, може да се извърши ендоваскуларно или хирургично. Трансвенозното отстраняване е възможна опция за електродите с активна фиксация, докато отстраняването на електродите с пасивна фиксация е за предпочитане да се извърши хирургично, поради обемистия връх на електрода, който може да увреди сърдечните кухини и съдовете. В тази статия представяме случай на масивна вентрикуларна перфорация от камерен електрод с пасивна фиксация, допълнително усложнена от сърдечна тампонада. Хирургичното отстраняване беше лечението на избор в нашия случай, с последващо имплантиране на постоянен двукухинен електрокардиостимулатор. Cardiac implantable electronic devices (CIEDs) implantation procedure has a complication rate of 5-6% according to most studies. Lead perforation is a possible and serious adverse event which can present with a spectrum of symptoms from asymptomatic to sudden death. Diagnostic tools in case of suspected lead perforation are X-ray, transthoracic echocardiography, pacemaker interrogation and computed tomography with the last one being the gold standard. Lead extraction could be done endovascularly or surgically. Transvenous removal is a possible option for active fi xation leads, while removal of passive fi xation leads is preferably done surgically, because of the bulky tip of the lead, which could damage the heart chambers and the vessels. In this article, we present a case of a massive ventricular perforation from a passive fi xation lead, further complicated by a cardiac tamponade. Surgical removal was the treatment of choice with subsequent implantation of a permanent dual-chamber pacemaker.
- 31 December 2023
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 29 (4) , 97-100
Open AccessSubacute right ventricular perforation from a passive fixation pacemaker lead - a multidisciplinary diagnostic and management work-up
Процедурата за имплантиране на сърдечни имплантируеми електронни устройства (CIEDs) има процент на усложнения от около 5-6% според повечето проучвания. Перфорацията от електрод е възможно и сериозно нежелано събитие, което може да се прояви със спектър от симптоми – от липса на такива до внезапна сърдечна смърт. Средствата за диагностика при съмнение за перфорация са рентгеново изследване, трансторакална ехокардиография, изследване на пейсмейкърната функция и компютърна томография, като последната е златен стандарт. Екстракццията на електрода, довел до перфорацията, може да се извърши ендоваскуларно или хирургично. Трансвенозното отстраняване е възможна опция за електродите с активна фиксация, докато отстраняването на електродите с пасивна фиксация е за предпочитане да се извърши хирургично, поради обемистия връх на електрода, който може да увреди сърдечните кухини и съдовете. В тази статия представяме случай на масивна вентрикуларна перфорация от камерен електрод с пасивна фиксация, допълнително усложнена от сърдечна тампонада. Хирургичното отстраняване беше лечението на избор в нашия случай, с последващо имплантиране на постоянен двукухинен електрокардиостимулатор. Cardiac implantable electronic devices (CIEDs) implantation procedure has a complication rate of 5-6% according to most studies. Lead perforation is a possible and serious adverse event which can present with a spectrum of symptoms from asymptomatic to sudden death. Diagnostic tools in case of suspected lead perforation are X-ray, transthoracic echocardiography, pacemaker interrogation and computed tomography with the last one being the gold standard. Lead extraction could be done endovascularly or surgically. Transvenous removal is a possible option for active fi xation leads, while removal of passive fi xation leads is preferably done surgically, because of the bulky tip of the lead, which could damage the heart chambers and the vessels. In this article, we present a case of a massive ventricular perforation from a passive fi xation lead, further complicated by a cardiac tamponade. Surgical removal was the treatment of choice with subsequent implantation of a permanent dual-chamber pacemaker.
- 10 May 2023
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (S2) , 562-565
Radical Open Resection of Incidentally Discovered Stage IB Synovial Sarcoma of the Diaphragm in a 64-Year-Old Man
- 10 May 2023
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (S2) , 562-565
Radical Open Resection of Incidentally Discovered Stage IB Synovial Sarcoma of the Diaphragm in a 64-Year-Old Man
- Open Access
- 30 April 2023
- Published by Pensoft Publishers in Folia Medica
- Vol. 65 (2) , 336-342
Cardiac echinococcosis, a multidisciplinary approach in the diagnosis and treatment of this rare entity: two case reports and literature review
We present two case reports of cardiac echinococcosis. Case 1 was a 33-year-old woman with hepatic and cardiac echinococcosis. The parasitic cyst was located intramyocardially in the free wall of the left ventricle leading to cranial dislocation of the left circumflex coronary artery (LCx). The patient was successfully operated. Case 2 was a 28-year-old woman with hepatic and cardiac echinococcosis. The parasitic cyst was located in the left ventricular myocardium in the area of the apex and manifested clinically as paroxysms of ventricular tachycardia. The ultrasound study showed a 3.2×2.8 cm cyst dislocating the papillary muscles and causing moderate mitral regurgitation.Bulgaria ranks first in the European Union in terms of the number of echinococcosis patients. Although cardiac involvement is uncommon, occurring in only 0.5%–2% of cases, it can cause a wide range of clinical symptoms. Multimodal imaging is a key step in the management of patients with cardiac involvement.
- 30 April 2023
- Published by Pensoft Publishers in Folia Medica
- Vol. 65 (2) , 336-342
Open AccessCardiac echinococcosis, a multidisciplinary approach in the diagnosis and treatment of this rare entity: two case reports and literature review
We present two case reports of cardiac echinococcosis. Case 1 was a 33-year-old woman with hepatic and cardiac echinococcosis. The parasitic cyst was located intramyocardially in the free wall of the left ventricle leading to cranial dislocation of the left circumflex coronary artery (LCx). The patient was successfully operated. Case 2 was a 28-year-old woman with hepatic and cardiac echinococcosis. The parasitic cyst was located in the left ventricular myocardium in the area of the apex and manifested clinically as paroxysms of ventricular tachycardia. The ultrasound study showed a 3.2×2.8 cm cyst dislocating the papillary muscles and causing moderate mitral regurgitation.Bulgaria ranks first in the European Union in terms of the number of echinococcosis patients. Although cardiac involvement is uncommon, occurring in only 0.5%–2% of cases, it can cause a wide range of clinical symptoms. Multimodal imaging is a key step in the management of patients with cardiac involvement.